HNGE

Hinge Health, Inc.
NYSEHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$9.34B
P/E Ratio
31.37
EPS
$3.69
Beta
—
52W High
$124.94
52W Low
$30.08
50-Day MA
$100.38
200-Day MA
$68.55
Dividend Yield
—
Profit Margin
21.00%
Forward P/E
38.61
PEG Ratio
—

About Hinge Health, Inc.

Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$800.82M
Gross Profit (TTM)$687.05M
EBITDA$152.38M
Operating Margin22.50%
Return on Equity47.60%
Return on Assets11.40%
Revenue/Share (TTM)$10.06
Book Value$3.70
Price-to-Book31.26
Price-to-Sales (TTM)11.66
EV/Revenue11.36
EV/EBITDA58.41
Quarterly Earnings Growth (YoY)-68.40%
Quarterly Revenue Growth (YoY)52.40%
Shares Outstanding$62.47M
Float$50.73M
% Insiders4.74%
% Institutions99.49%

Historical Volatility

HV 10-Day
34.20%
HV 20-Day
41.20%
HV 30-Day
38.65%
HV 60-Day
40.30%
HV Rank
9.9%

Volatility is currently contracting

Analyst Ratings

Consensus ($131.75 target)
7
Strong Buy
9
Buy
1
Hold

Latest News

What Hinge Health (HNGE) Said on Its Q3 Earnings Call

Hinge Health NYSE: HNGE reported third-quarter revenue growth of 52% year over year and raised its full-year outlook, as the digital musculoskeletal care company cited higher member engagement, client additions and improved operating leverage.

MarketBeat11/3/2026Positive
Hinge Health reports record third quarter 2026 financial results

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2026 and provided a business update. “Our strong performance continues to reflect our ability to deliver exceptional clinical outcomes, a better healthcare experience and lower client costs at scale," said Daniel Perez, Co-Founder and CEO, Hinge Health. "This focus on the triple aim, via a technology platform that scales and automates care delivery, is also.

Business Wire11/2/2026Neutral
Hinge Health to announce third quarter 2026 financial results on November 2, 2026

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2026, after the U.S. financial markets close on Monday, November 2, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relation.

Business Wire10/5/2026Neutral
3 Healthcare Stocks Showing Why the Sector Still Has Momentum

The healthcare sector has performed fairly well so far in 2026 due to several factors: GLP-1 medications continue to drive new business and interest, while groundbreaking AI applications help enhance and accelerate the drug discovery process. On top of that, potential mergers and acquisitions activity, as big pharmaceutical companies face a major patent cliff, could provide opportunities for new firms to stand out.

MarketBeat9/28/2026Positive
Baron Small Cap Fund Q2 2026 Portfolio Activity

Baron Small Cap Fund (the Fund) was up 12.57% (Institutional Shares) in the second quarter, trailing the Russell 2000 Growth Index (the Index) by 13.14%, as the Index was up 25.71%. Shares increased during the quarter as Vertiv reported strong Q1 financial results (adjusted earnings per share increased 83% year-over-year) and increased fiscal year guidance fueled by organic sales growth of around 30%. Planet Fitness, Inc. , the leading high-value, low-cost gym operator, detracted from performance in the second quarter after the company lowered full-year guidance following weaker-than-expected member additions in the first quarter.

Seeking Alpha9/2/2026Neutral
15 Stocks to Watch With Short Squeeze Potential

Bond yields have the entire stock market on edge. The last thing most investors are thinking about is short squeezes, which means maybe they should be something contrarian trades have on their radar.

Schaeffers Research9/2/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HNGE and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 11/7/2026